Antiplatelet Theray in Patientswith Coronary Heart Disease After Inplantation of Drug Eluting Stents
Keywords:
coronary heart disease, dual antiplatelet therapy, percutaneous coronary intervention
Abstract
The article touched upon issues related to dual antiplatelet therapy after DES stent implantation in patients with coronary artery disease.
References
1. Wiviott S.D., Braunwald E., McCabe C.H., Montalescot G., Ruzyllo W., Gottlieb S., Neumann F.J., Ardissino D., De Servi S., Murphy S.A., Riesmeyer J., Weerakkody G., Gibson C.M., Antman E.M.; TRITON-TIMI 38 Investigators. N Engl J Med 2007; 357: 2001-2015.
2. Hughes S. TRITON-TIMI 38: What role for prasugrel in ACSwww.theheart.org. November 5, 2007.
3. The effect of acetylsalicylic acid and clopidogrel on the structural and functional state of erythrocytes in acute coronary syndrome A.L. Alavi, R.A. Rakhimova, B.A. Alavi. Rational Pharmacotherapy in Cardiology 2009; No. 5.
4. Some aspects of the efficacy and safety of statins and antiplatelet agents in coronary heart disease after interventional intervention. BA Alavi, AH Abdullayev, NR Raimkulova, MM Karimov, LCD Uzokov, SHA Iskhakov.
5. Transition between antiplatelet therapy regimens. Alternatives to clopidogrel in patients with acute coronary syndrome who are scheduled for percutaneous coronary angioplasty: Sh.Azmun, D. Angiolillo 2014.
6. Kelly R.P., Close S.L., Farid N.A., Winters K.J., Shen L., Natanegara F. et al. 2012. Pharmacokinetics and pharmacodynamics of maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variants. Br J Clin Pharmacol. 73
7. Mauri L., Kerejakes D. D., Ye R. V. et al. 2014. Twelve or 30 months of double antiplatelet therapy after drug-coated stents. N Engl J Med. 371
8. http://www.escardio.org/ guidelines
2. Hughes S. TRITON-TIMI 38: What role for prasugrel in ACSwww.theheart.org. November 5, 2007.
3. The effect of acetylsalicylic acid and clopidogrel on the structural and functional state of erythrocytes in acute coronary syndrome A.L. Alavi, R.A. Rakhimova, B.A. Alavi. Rational Pharmacotherapy in Cardiology 2009; No. 5.
4. Some aspects of the efficacy and safety of statins and antiplatelet agents in coronary heart disease after interventional intervention. BA Alavi, AH Abdullayev, NR Raimkulova, MM Karimov, LCD Uzokov, SHA Iskhakov.
5. Transition between antiplatelet therapy regimens. Alternatives to clopidogrel in patients with acute coronary syndrome who are scheduled for percutaneous coronary angioplasty: Sh.Azmun, D. Angiolillo 2014.
6. Kelly R.P., Close S.L., Farid N.A., Winters K.J., Shen L., Natanegara F. et al. 2012. Pharmacokinetics and pharmacodynamics of maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variants. Br J Clin Pharmacol. 73
7. Mauri L., Kerejakes D. D., Ye R. V. et al. 2014. Twelve or 30 months of double antiplatelet therapy after drug-coated stents. N Engl J Med. 371
8. http://www.escardio.org/ guidelines
Published
2022-10-31
How to Cite
Dilshod, U., Omina, M., & Yulduz, Y. (2022). Antiplatelet Theray in Patientswith Coronary Heart Disease After Inplantation of Drug Eluting Stents. Central Asian Journal of Medical and Natural Science, 3(5), 697-701. https://doi.org/10.17605/cajmns.v3i5.1158
Section
Articles
